March 27, 2023: NCHR comments on the new FDA standards for lead in food for babies and young children. Standards must be implemented as soon as possible and should be enforced.
Read More »Author: Caroline Bradford
NCHR Comment on USPSTF Draft Research Plan on Interventions to Prevent Perinatal Depression
We appreciate efforts by the US Preventive Services Task Force to reduce perinatal depression, which is one of the most common complications of pregnancy. Perinatal depression contributes significantly to maternal mortality and adverse neonatal, infant, and child outcomes. We agree that developing effective interventions to prevent perinatal depression is essential to reduce the U.S. maternal mortality rate.
Read More »NCHR Comment On USPSTF Draft Recommendation On Folic Acid Supplementation To Prevent Neural Tube Defects
Neural tube defects are among the most common causes of childhood mortality and disability. In its new draft recommendation, the US Preventive Services Task Force reaffirms that folic acid supplementation provides a substantial benefit for reproductive-aged women in reducing the risk of neural tube defects. The task force also highlights areas that require further study, including disparities in the prevalence of neural tube defects. We agree.
Read More »NCHR Comments on the Use of Medical Device User Fees Collected by FDA
March 20, 2023: In a public comment, we explain our concerns about FDA’s plan to distribute user fee funding to non-governmental organizations to support premarket real world evidence (RWE).
Read More »For Canadian Patients, Therapeutic Psychedelics Beset by Red Tape
Undark, March 8, 2023: Undark article reviews the red tape in Canada vs. U.S. for access to psychedelics for cancer patients and other depressed patients. In this news article, we explain FDA expanded access program, which tends to make access easier if companies agree to help patients.
Read More »